Join to view full profile
1275 York AveNew York, NY 10065
Phone+1 212-639-2000
Dr. Sfakianos is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
SUNY Downstate Health Sciences UniversityResidency, Urology, 2008 - 2012- SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 2007 - 2008
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007
Certifications & Licensure
NY State Medical License 2012 - 2027
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015
Publications & Presentations
PubMed
- Bladder preservation with systemic therapy alone: are we losing sight of survival?Alec Zhu, Pierre-Etienne Gabriel, John P Sfakianos
BJU International. 2026-11-01 - Editorial Comment.Alec Zhu, Pierre-Etienne Gabriel, John P Sfakianos
The Journal of Urology. 2026-11-01 - The Role of Biomarkers in the Management of Muscle-Invasive Bladder Cancer.Alec Zhu, Ahmed Eraky, Pierre-Etienne Gabriel, John P Sfakianos
The Urologic Clinics of North America. 2026-11-01
Journal Articles
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesIsuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology
Authored Content
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018
Press Mentions
Mount Sinai’s Cancer Science in the Spotlight at 2025 ASCOMay 29th, 2025- New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
- Ask the Expert: John Sfakianos, M.D.June 17th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
